ATE150796T1 - Karakterisierung von hla-dqbeta-dns - Google Patents

Karakterisierung von hla-dqbeta-dns

Info

Publication number
ATE150796T1
ATE150796T1 AT92902628T AT92902628T ATE150796T1 AT E150796 T1 ATE150796 T1 AT E150796T1 AT 92902628 T AT92902628 T AT 92902628T AT 92902628 T AT92902628 T AT 92902628T AT E150796 T1 ATE150796 T1 AT E150796T1
Authority
AT
Austria
Prior art keywords
dna
typing
hla
dqbeta
characterization
Prior art date
Application number
AT92902628T
Other languages
English (en)
Inventor
Henry A Erlich
Teodorica Bugawan
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE150796T1 publication Critical patent/ATE150796T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/686Polymerase chain reaction [PCR]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/172Haplotypes
AT92902628T 1990-12-21 1991-12-20 Karakterisierung von hla-dqbeta-dns ATE150796T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63218090A 1990-12-21 1990-12-21
PCT/US1991/009796 WO1992011389A1 (en) 1990-12-21 1991-12-20 Hla dqbeta dna typing

Publications (1)

Publication Number Publication Date
ATE150796T1 true ATE150796T1 (de) 1997-04-15

Family

ID=24534416

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92902628T ATE150796T1 (de) 1990-12-21 1991-12-20 Karakterisierung von hla-dqbeta-dns

Country Status (10)

Country Link
EP (1) EP0515660B1 (de)
JP (1) JP3228738B2 (de)
AT (1) ATE150796T1 (de)
AU (1) AU656549B2 (de)
CA (1) CA2075052C (de)
DE (1) DE69125368T2 (de)
DK (1) DK0515660T3 (de)
ES (1) ES2101083T3 (de)
GR (1) GR3023863T3 (de)
WO (1) WO1992011389A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6818393B1 (en) 1982-07-30 2004-11-16 Biomirieux Sa DNA sequences coding for the DR beta-chain locus of the human lymphocyte antigen complex and polypeptides, diagnostic typing processes and products related thereto
FR2684688B1 (fr) * 1991-12-04 1994-03-18 Bertin Et Cie Procede de selection d'au moins un crible de mutations, son application a un procede d'identification rapide d'alleles de systemes polymorphes et dispositif pour sa mise en óoeuvre.
FR2749308B1 (fr) * 1996-06-03 1998-07-24 Bio Merieux Sondes nucleotidiques et procede pour determiner le typage hla dqb1
EP1025261A4 (de) * 1997-02-21 2004-05-12 Saigene Corp Zusammensetzungen und methoden zur bestimmung der prädisposition für insulin-abhängigen diabetes mellitus
JP3907353B2 (ja) 1999-08-26 2007-04-18 株式会社タニタ 生体インピーダンス測定装置
PT1296713E (pt) * 2000-06-08 2004-02-27 Intercell Biomediz Forschungs Oligodesoxinucleotidos imunoestimuladores
FR2816958B1 (fr) * 2000-11-17 2004-11-26 Biomerieux Sa Procede d'analyse de la predisposition genetique d'un patient au diabete insulino-dependant, dispositif adapte a sa mise en oeuvre et jeu d'amorces d'amplification adapte a un tel procede
DE602004018270D1 (de) 2003-01-17 2009-01-22 Eragen Biosciences Inc Nukleinsäureamplifikation mit nichtstandardbasen
AU2004227353B2 (en) 2003-04-01 2010-02-25 Luminex Corporation Polymerase inhibitor and method of using same
EP1893777B1 (de) 2005-06-07 2014-10-01 Luminex Corporation Verfahren zum nachweis und zur typisierung von nukleinsäuren
CN103270170B (zh) * 2010-12-24 2015-07-29 深圳华大基因医学有限公司 Hla-dqb1基因分型的方法及其相关引物
WO2013149086A1 (en) 2012-03-28 2013-10-03 Somalogic, Inc. Aptamers to pdgf and vegf and their use in treating pdgf and vegf mediated conditions
CA3221709A1 (en) 2013-09-09 2015-03-12 Somalogic Operating Co., Inc. Pdgf and vegf aptamers having improved stability and their use in treating pdgf and vegf mediated diseases and disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6194561B1 (en) * 1986-03-13 2001-02-27 Roche Molecular Systems, Inc. Characterization and detection of sequences associated with autoimmune diseases
US5310893A (en) * 1986-03-31 1994-05-10 Hoffmann-La Roche Inc. Method for HLA DP typing
CA1284931C (en) * 1986-03-13 1991-06-18 Henry A. Erlich Process for detecting specific nucleotide variations and genetic polymorphisms present in nucleic acids
US4965189A (en) * 1986-07-01 1990-10-23 University Of Massachusetts Medical School Probes for the determination of the proclivity for development of autoimmune diseases
US5039606A (en) * 1987-10-29 1991-08-13 Virginia Mason Research Center Diagnostic probe for diabetes type I predisposition

Also Published As

Publication number Publication date
EP0515660B1 (de) 1997-03-26
DK0515660T3 (da) 1997-07-28
CA2075052A1 (en) 1992-06-22
ES2101083T3 (es) 1997-07-01
AU656549B2 (en) 1995-02-09
DE69125368D1 (de) 1997-04-30
DE69125368T2 (de) 1997-10-09
AU9136891A (en) 1992-07-22
GR3023863T3 (en) 1997-09-30
CA2075052C (en) 2006-08-22
WO1992011389A1 (en) 1992-07-09
JP3228738B2 (ja) 2001-11-12
EP0515660A1 (de) 1992-12-02
JPH05506365A (ja) 1993-09-22

Similar Documents

Publication Publication Date Title
NZ218865A (en) Preparing samples for detecting of specific dna sequences
ATE150796T1 (de) Karakterisierung von hla-dqbeta-dns
DE3853678T2 (de) Verfahren zum nachweis des karzinogenen menschlichen papillomavirus.
KR930010192A (ko) 에이치엘에이(hla) 제i형 디엠에이(dna) 타이핑 방법 및 시약
ATE164187T1 (de) Verfahren zum nachweis htlvi- und htlvii-viren mittels hybridizierung
ATE92538T1 (de) Verstaerkung und nachweis von nukleinsaeuresequenzen.
DK0514534T3 (da) Fremgangsmåder og reagenser til HLA DRbeta-DNA-typebestemmelse
TNSN89026A1 (fr) Methode de detection de sequences de nucleotides
DE3486496D1 (de) Verfahren und Strukturen, in welchen chemisch markierte nichtradioaktive Polynukleotidesonden benutzt werden
DE69031911T2 (de) Verfahren zum nachweis von picornaviren in biologischen flüssigkeiten und geweben
SE8800864D0 (sv) Method of assaying of nucleic acids, a reagent combination and kit therefore
ATE368125T1 (de) Verfahren zur erkennung von einzel-nukleotid- polymorphismen
DE3876108D1 (de) Diagnostischer test unter verwendung von nucleinsaeure-sonden.
ATE133715T1 (de) Verfahren zum nachweis von gesplei ter mrna
ATE360092T1 (de) Nukleinsäureprimer und -sonden zur detektion onkogener humaner papillomaviren
KR970704891A (ko) Hla-dr 타입 결정용 프로브 시스템 및 이를 이용한 타입 결정 방법
DE69610933T2 (de) Verfahren und reagenzien zur typisierung von hla-genen der klasse i
Apple et al. Methods and reagents for HLA class I a locus DNA typing

Legal Events

Date Code Title Description
EELA Cancelled due to lapse of time